These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance). Roboz GJ; Mandrekar SJ; Desai P; Laumann K; Walker AR; Wang ES; Kolitz JE; Powell BL; Attar EC; Stock W; Bloomfield CD; Kohlschmidt J; Mrózek K; Hassane DC; Garraway L; Jané-Valbuena J; Baltay M; Tracy A; Marcucci G; Stone RM; Larson RA Blood Adv; 2018 Dec; 2(24):3608-3617. PubMed ID: 30567725 [TBL] [Abstract][Full Text] [Related]
8. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Deschler B; Ihorst G; Platzbecker U; Germing U; März E; de Figuerido M; Fritzsche K; Haas P; Salih HR; Giagounidis A; Selleslag D; Labar B; de Witte T; Wijermans P; Lübbert M Haematologica; 2013 Feb; 98(2):208-16. PubMed ID: 22875615 [TBL] [Abstract][Full Text] [Related]
19. Geriatric assessment predicts nonfatal toxicities and survival for intensively treated older adults with AML. Min GJ; Cho BS; Park SS; Park S; Jeon YW; Shin SH; Yahng SA; Yoon JH; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Hee-Je K Blood; 2022 Mar; 139(11):1646-1658. PubMed ID: 35007323 [TBL] [Abstract][Full Text] [Related]
20. Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains. Woods JD; Zeidner JF; Van Deventer HW; Jamieson K; Matson M; Zhang J; Pulley W; Brenizer T; Muss H; Nyrop KA; Vohra SN; Deal AM; Ivanova A; Foster MC J Geriatr Oncol; 2022 May; 13(4):499-504. PubMed ID: 34955443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]